Ubidecarenone

Drug Profile

Ubidecarenone

Alternative Names: Bio-Quinone Q10; Coenzyme Q10; CoQ10; Neuquinon; Q-Gel; UbiQGel; Ubiquinone; Vitaline; Vitaline CoQ10

Latest Information Update: 19 Apr 2006

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Eisai Co Ltd; Enzymatic Therapy; Nonindustrial source; Pharma Nord; Tishcon Corporation
  • Developer Enzymatic Therapy; Pharma Nord; Tishcon Corporation
  • Class Antihyperlipidaemics; Antineoplastics; Benzoquinones; Cardiotonics; Cardiovascular therapies; Coenzymes; Small molecules
  • Mechanism of Action Antioxidants; Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Huntington's disease
  • New Molecular Entity No

Highest Development Phases

  • Marketed Heart failure
  • Discontinued Fibromyalgia; Huntington's disease; Immunodeficiency disorders; Metabolic disorders; Myocardial infarction; Neurological disorders; Parkinson's disease; Reperfusion injury; Stroke

Most Recent Events

  • 16 Feb 2016 Biomarkers information updated
  • 19 Apr 2006 Phase-I clinical trials in Neurological disorders in USA (PO)
  • 19 Apr 2006 Data presented at the 58th Annual Meeting of the American Academy of Neurology (AAN-2006) have been added to the adverse events and Neurological disorders therapeutic trials sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top